Literature DB >> 20937445

Treatment and control of high blood pressure in adults.

George A Mensah1, George Bakris.   

Abstract

Hypertension and prehypertension are major public health challenges. Prevention and control of prehypertension through lifestyle changes and the treatment of hypertension to goal blood pressure (BP) are important objectives. In most patients, 2 or more medications with complementary mechanisms of action should be used in combination. Referral for evaluation of resistant hypertension should be made when goal BP is not attained while patients are adherent on 3 or more appropriately dosed antihypertensive medications, including a diuretic. There are compelling indications for the use of specific drugs in patients with underlying ischemic heart disease, chronic heart failure, diabetes, chronic kidney disease, stroke, peripheral arterial disease, left ventricular hypertrophy, obesity, and metabolic syndrome. Adverse drug effects should be identified early and managed promptly to address patient safety and adherence. Other factors that affect adherence include the patient's health literacy level and ability to self-manage. The social, environmental, cultural, and financial sources of support in care must be addressed to achieve the full benefits of treatment and control of hypertension and prehypertension.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937445     DOI: 10.1016/j.ccl.2010.08.002

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  9 in total

1.  Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial.

Authors:  Nelson Wang; Abdul Salam; Ruth Webster; Asita de Silva; Rama Guggilla; Sandrine Stepien; Jayanthi Mysore; Laurent Billot; Stephen Jan; Pallab K Maulik; Nitish Naik; Vanessa Selak; Simon Thom; Dorairaj Prabhakaran; Anushka Patel; Anthony Rodgers
Journal:  JAMA Cardiol       Date:  2020-11-01       Impact factor: 14.676

2.  Differential Effects of Combination of Renin-Angiotensin-Aldosterone System Inhibitors on Central Aortic Blood Pressure: A Cross-Sectional Observational Study in Hypertensive Outpatients.

Authors:  Akshyaya Pradhan; Pravesh Vishwakarma; Monika Bhandari; Rishi Sethi; Varun Shankar Narain
Journal:  Cardiovasc Ther       Date:  2020-09-07       Impact factor: 3.023

3.  The United Nations high level meeting addresses noncommunicable diseases, but where is hypertension?

Authors:  George A Mensah; George Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-09-20       Impact factor: 3.738

4.  Correlation between sleep duration and hypertension: a dose-response meta-analysis.

Authors:  Hui Li; Yu Ren; Yun Wu; Xingsheng Zhao
Journal:  J Hum Hypertens       Date:  2018-11-19       Impact factor: 3.012

5.  Use of family member-based supervision in the management of patients with hypertension in rural China.

Authors:  Susan Huang; Ye Chen; Jing Zhou; Jianming Wang
Journal:  Patient Prefer Adherence       Date:  2014-07-31       Impact factor: 2.711

6.  Family member-based supervision of patients with hypertension: a cluster randomized trial in rural China.

Authors:  Y Shen; X Peng; M Wang; X Zheng; G Xu; L Lü; K Xu; B Burstrom; K Burstrom; J Wang
Journal:  J Hum Hypertens       Date:  2016-02-25       Impact factor: 3.012

7.  The Integrity of the Corpus Callosum Mitigates the Impact of Blood Pressure on the Ventral Attention Network and Information Processing Speed in Healthy Adults.

Authors:  Nichol M L Wong; Ernie Po-Wing Ma; Tatia M C Lee
Journal:  Front Aging Neurosci       Date:  2017-04-24       Impact factor: 5.750

8.  Treatment patterns of antihypertensive fixed-dose combinations according to age and number of agents prescribed: Retrospective analysis using a Japanese claims database.

Authors:  Takayuki Ishida; Akinori Oh; Nobuhiro Nishigaki; Takuya Tsuchihashi
Journal:  Geriatr Gerontol Int       Date:  2019-08-21       Impact factor: 2.730

9.  Scaling up effective treatment of hypertension-A pathfinder for universal health coverage.

Authors:  Thomas R Frieden; Cherian V Varghese; Sandeep P Kishore; Norman R C Campbell; Andrew E Moran; Raj Padwal; Marc G Jaffe
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-23       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.